Expandable Volume-Filling Leads for Tumor Electric Field Therapy
Solution Overview
Problem
Current treatments for cancerous tumors, such as surgery, radiation therapy, and chemotherapy, often come with undesirable side effects, and there is a need for alternative methods to effectively target and eliminate cancer cells at the cellular division stage.
Innovation Solution
The development of medical devices featuring volume-filling leads with expandable heads and electrodes that generate therapeutic electric fields to disrupt mitosis in cancerous cells by interfering with microtubule spindle formation and electric field density, inducing apoptosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments (surgery, radiation, chemotherapy) are used to treat cancerous tumors, then cancer cells can be eliminated, but undesirable side effects occur
Solution Approach 1:
The patent replaces conventional mechanical and chemical cancer treatments (surgery, chemotherapy) with an electric field-based system. The Tumor Field System uses electrodes to generate alternating electric fields that disrupt mitotic spindle formation in cancer cells, eliminating the need for invasive surgery and toxic chemotherapy agents while maintaining cancer cell elimination effectiveness
Solution Approach 2:
The patent changes the physical parameters of cancer treatment from mechanical force and chemical exposure to electric field parameters (frequency, voltage, electrode configuration). By optimizing these electric field parameters to match the mitotic frequency of cancer cells, the system achieves selective disruption of cancer cell division without affecting normal cells, thereby reducing side effects
2Reliability
If electrodes are positioned to generate electric fields for disrupting mitosis, then cancer cells can be targeted, but precise positioning and field density control are required
Solution Approach 1:
The patent divides the treatment system into multiple electrodes that can be positioned around the tumor site. Each electrode contributes to the overall electric field, and by segmenting the system into manageable electrode components, the complex task of field generation is simplified while maintaining precise targeting capability
Solution Approach 2:
The patent designs the electrode system to serve multiple functions: positioning electrodes to define treatment volume, generating the therapeutic electric field, and potentially monitoring treatment delivery. This multi-functionality reduces the need for separate systems and simplifies the overall device complexity while maintaining targeting accuracy
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively halts cellular division and induces programmed cell death in cancerous cells, providing a minimally invasive treatment option with reduced side effects by targeting cancer cells at the site of the tumor.
Implementation Method 1
electrodes configured to generate therapeutic electric fields at the site of a cancerous tumor
Data Source
Figure 1~2
Figure 3~4
Figure 5
AI summary
Embodiments herein relate to medical devices including volume filling leads and methods of use to treat cancerous tumors within a bodily tissue. In an embodiment, a lead for a cancer treatment system is described. The lead can include a lead body having a proximal end and a distal end, where the lead body can define a lumen. The lead can include an expandable lead head connected to the distal end of the lead body, where the lead head can be configured to be expanded between a first non-expanded position and a second expanded position in order to fill an intracorporeal void. The lead can include two or more electrodes disposed on an outer surface of the lead head and two or more electrical conductors configured to provide electrical communication between the two or more electrodes and the proximal end of the lead body. Other embodiments are also included herein.
